Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Treatment of Metastatic Colorectal Cancer Based on Genetic Markers

NCT00396487 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT00396487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00396487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Treatment of Metastatic Colorectal Cancer Based on Genetic Markers
Lead sponsor
Vejle Hospital
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2006
Completion date
February 29, 2008
Enrollment
1 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer